Bariatric Surgery in Obese Patients With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 72 of the 78 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: There is a paucity of data on the impact of bariatric surgery in type 1 diabetes (T1D). The aim of this review was to quantify the overall effects of bariatric surgery in obese patients with T1D. METHODS: We searched PubMed, Scopus, ISI Web of Knowledge, and Google Scholar from their inception to December 2015 to identify all relevant studies of bariatric surgery in adult obese patients with T1D. RESULTS: The review included 17 studies with 107 individuals, including 10 case series and 7 case reports. Overall, the dominant procedure was gastric bypass (n = 70; 65%). All studies reported a significant reduction in excess weight. A significant reduction in weight-adjusted daily insulin requirements was shown in all case series except one. Pooled mean ± SD of pre- and postoperative glycated hemoglobin (HbA1c) for the entire cohort with available data (n = 96) was 8.4 ± 1.3% and 7.9 ± 1.1%, respectively (P = 0.01). In addition to common postoperative complications, profound glycemic changes (diabetic ketoacidosis and hypoglycemia) and gastrointestinal dysmotility symptoms (prolonged ileus and acute gastric remnant dilation) have been reported. No surgical mortality was reported. CONCLUSIONS: Bariatric surgery leads to significant weight loss in severely obese patients with T1D and results in a significant improvement in insulin requirements and glycemic status. The favorable metabolic effects of bariatric surgery may facilitate medical management of and cardiovascular risk reduction in T1D in the setting of severe obesity. Diabetic ketoacidosis and hypoglycemia are potentially serious complications. Short-term results of bariatric surgery in patients with T1D are encouraging, but larger and longer-term studies are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 1×
“In appropriate-risk patients with T1D, gastric bypass offers a treatment option with a risk/benefit profile that lies between purely restrictive (gastric banding) and malabsorptive (duodenal switch) procedures (12,19,22,27,49).”
BackgroundBariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901 · cited 2×
“complications including cardiovascular diseases, nephropathy, retinopathy, and mortality at long-term follow-up (28), while enhancing patients’ quality of life (22).”
BackgroundSelf-citationBariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Long-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Perioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392
Epidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092 · cited 1×
“Large epidemiologic studies indicate that the worldwide incidence of T1D has been increasing in recent decades (1,2).”
BackgroundDaneman, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68341-4 · Cited by 921
Ikramuddin, S., Korner, J., Lee, W.-J., Connett, J. E., Inabnet, W. B., Billington, C. J., Thomas, A. J., Leslie, D. B., Chong, K., Jeffery, R. W., et al. (2013) · JAMA · doi:10.1001/jama.2013.5835 · Cited by 735
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
“In addition, metabolic surgery in appropriate candidates can decrease body weight and improve glycemia (197,198).”
O'Kane, M., Parretti, H. M., Pinkney, J., Welbourn, R., Hughes, C. A., Mok, J., Walker, N., Thomas, D., Devin, J., Coulman, K. D., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13087 · Cited by 338
Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity
Aminian, A., Brethauer, S. A., Andalib, A., Nowacki, A. S., Jimenez, A., Corcelles, R., Hanipah, Z. N., Punchai, S., Bhatt, D. L., Kashyap, S. R., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002407 · Cited by 256
Self-citationAmerican Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s008 · Cited by 244
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s008 · Cited by 244
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s008 · Cited by 236
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s008 · Cited by 213
Obesity in people living with type 1 diabetes
Van der Schueren, B., Ellis, D., Faradji, R. N., Al-Ozairi, E., Rosen, J., & Mathieu, C. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00246-1 · Cited by 185
Pareek, M., Schauer, P. R., Kaplan, L. M., Leiter, L. A., Rubino, F., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.014 · Cited by 177
Self-citationEuglycemic diabetic ketoacidosis
Barski, L., Eshkoli, T., Brandstaetter, E., & Jotkowitz, A. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.03.014 · Cited by 176
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s008 · Cited by 158
Weight management in patients with type 1 diabetes and obesity
Mottalib, A., Kasetty, M., Mar, J. Y., Elseaidy, T., Ashrafzadeh, S., & Hamdy, O. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0918-8 · Cited by 149
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s008 · Cited by 149
“Although metabolic surgery has been shown to improve the metabolic profiles of patients with type 1 diabetes and morbid obesity, establishing the role of metabolic surgery in such patients will require larger and longer studies (76).”
BackgroundAmerican Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s008 · Cited by 148
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s007 · Cited by 117
“Although metabolic surgery has been shown to improve the metabolic profiles of morbidly obese patients with type 1 diabetes, establishing the role of metabolic surgery in such patients will require larger and longer studies (72).”
BackgroundObesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges
Vilarrasa, N., San Jose, P., Rubio, M. Á., & Lecube, A. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s223618 · Cited by 88
Diagnóstico e Tratamento da Cetoacidose Diabética Euglicêmica
Santomauro, A. T. M. G., Junior, A. C. S., Raduan, R. A., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-22 · Cited by 83
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s008 · Cited by 165
7. Obesity Management for the Treatment of Type 2 Diabetes
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s010 · Cited by 88
“Although metabolic surgery has been shown to improve themetabolic profiles of morbidly obese patients with type 1 diabetes, establishing the role of metabolic surgery in such patients will require larger and longer studies (61).”
BackgroundPrevention of Cardiovascular Disease in Type 1 Diabetes
Manrique‐Acevedo, C., Hirsch, I. B., & Eckel, R. H. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2311526 · Cited by 79
Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care
Cefalu, W. T., Rubino, F., & Cummings, D. E. (2016) · Diabetes Care · doi:10.2337/dc16-0686 · Cited by 65
“atric surgery in patients with T1D are encouraging, but larger and longerterm studies are needed” (48).”
BackgroundMeasuring ketone bodies for the monitoring of pathologic and therapeutic ketosis
Anderson, J. C., Mattar, S. G., Greenway, F. L., & Lindquist, R. J. (2021) · Obesity Science & Practice · doi:10.1002/osp4.516 · Cited by 57
Aminian, A., Aleassa, E. M., Bhatt, D. L., Tu, C., Khorgami, Z., Schauer, P. R., Brethauer, S. A., & Daigle, C. R. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13765 · Cited by 47
“For instance, it is now well established that bariatric surgery is an extremely effective and durable treatment for type 2 diabetes (T2D) and its associated end-organ derangements.(1-6) These significant metabolic improvements have also been shown to be capable of improving quality of life and overall survival.”
BackgroundSelf-citationLong-Term Outcomes in Patients with Morbid Obesity and Type 1 Diabetes Undergoing Bariatric Surgery
Vilarrasa, N., Rubio, M. Á., Miñambres, I., Flores, L., Caixàs, A., Ciudin, A., Bueno, M., García‐Luna, P. P., Ballesteros-Pomar, M. D., de Adana, M. R., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2390-y · Cited by 55
“Recently, two systematic reviews have been published based on these case series and case reports [25, 26].”
BackgroundWu, D., Yan, Z.-B., Cheng, Y., Zhong, M., Liu, S.-Z., Zhang, G., & Hu, S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.10.015 · Cited by 41
Kenngott, H., Nickel, F., Wise, P. A., Wagner, F., Billeter, A. T., Nattenmüller, J., Nabers, D., Maier-Hein, K. H., Kauczor, H., Fischer, L., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04087-w · Cited by 41
Aktuelles zur Adipositas (mit und ohne Diabetes)
Hamann, A. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0241-7 · Cited by 39
Cantley, N. W. P., Lonnen, K., Kyrou, I., Tahrani, A. A., & Kahal, H. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00851-1 · Cited by 46
Should recent smoking be a contraindication for sleeve gastrectomy?
Haskins, I. N., Nowacki, A. S., Khorgami, Z., Schulz, K., Heinberg, L. J., Schauer, P. R., Brethauer, S. A., & Aminian, A. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.02.028 · Cited by 31
Self-citationHöskuldsdóttir, G., Ekelund, J., Miftaraj, M., Wallenius, V., Ottosson, J., Näslund, I., Gudbjörnsdottir, S., Sattar, N., Svensson, A.-M., & Eliasson, B. (2020) · Diabetes Care · doi:10.2337/dc20-0388 · Cited by 29
Bariatric surgery in patients with type 1 diabetes: special considerations are warranted
Landau, Z., Sandbank, G. K., Jakubowicz, D. J., Raziel, A., Sakran, N., Zaslavsky‐Paltiel, I., Lerner‐Geva, L., & Pinhas‐Hamiel, O. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818822207 · Cited by 30
Wei, X., Lu, Z., Li, L., Zhang, H., Sun, F., Ma, H., Wang, L., Hu, Y., Yan, Z., Zheng, H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108207 · Cited by 24
“In addition, in patients with T1DM, metabolic surgery also showed significant improvement in blood glucose status and insulin demand (Kirwan et al., 2016), and it also ameliorated the renal function of rats with T1DM by reversing the damage or loss of podocytes, the main structure of the filtration barrier”
BackgroundBariatric Surgery and Type 1 Diabetes: Unanswered Questions
Korakas, E., Kountouri, A., Raptis, A. E., Kokkinos, A. D., & Lambadiari, V. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.525909 · Cited by 26
“Among patients with T1DM, no excess in mortality has been reported (38).”
BackgroundManagement of Diabetes in Patients Undergoing Bariatric Surgery
Mulla, C. M., Baloch, H. M., & Hafida, S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1242-2 · Cited by 27
Dowsett, J., Humphreys, R., & Krones, R. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3548-6 · Cited by 21
Diabetes management before, during, and after bariatric and metabolic surgery
Kheniser, K. G., & Kashyap, S. R. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.06.006 · Cited by 20
Self-citationParmar, C. D., Appel, S., Lee, L., Ribeiro, R. J. D. S., Sakran, N., & Pouwels, S. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06321-4 · Cited by 19
“It might thus be a good option for postoperative glycemic management, reducing the risk of hypoglycemia in patients with T1DM [24, 48].”
BackgroundInfluenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations
Husein, N., & Chetty, A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.016 · Cited by 15
Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgery
Lu, Z., Wei, X., Sun, F., Zhang, H., Gao, P., Pu, Y., Wang, A., Chen, J., Tong, W., Li, Q., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0062-x · Cited by 15
Pitra, S., & Smith, B. N. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00368.2020 · Cited by 16
Sleeve Gastrectomy and Diabetes
Andalib, A., & Aminian, A. (2017) · Advances in Surgery · doi:10.1016/j.yasu.2017.03.003 · Cited by 18
Self-citationMorey‐Vargas, O. L., Aminian, A., Steckner, K., Zhou, K., Kashyap, S. R., Cetin, D. C., Pantalone, K. M., Daigle, C. R., Griebeler, M. L., Butsch, W. S., et al. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.05.008 · Cited by 14
Self-citationMohammed, N., Buckley, A. J., Elsheikh, M., Allum, M., Suliman, S., Hadad, M. A., le Roux, C. W., Lessan, N. G., & Suliman, M. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14369 · Cited by 14
“The median (range) time from surgery to the last visit assessment was 40 (2-117) months.”
BackgroundMoreno-Fernández, J., & Chico, A. I. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.09.002 · Cited by 12
Bariatric Surgery in Patients With Obesity and Latent Autoimmune Diabetes in Adults (LADA)
Aminian, A., Sharma, G., Wilson, R. L., Kashyap, S. R., Menzo, E. L., Szomstein, S., Rosenthal, R. J., Schauer, P. R., & Vangoitsenhoven, R. (2020) · Diabetes Care · doi:10.2337/dc19-2388 · Cited by 9
“Adult patients with latent autoimmune diabetes in adults (LADA) have a slower decline in b-cell function and lower requirement for insulin therapy than patients with classical young-onset type 1 diabetes (T1D) (3).”
ResultSelf-citationTsushima, Y., Zhou, K., Bena, J., & Kashyap, S. R. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.01.008 · Cited by 13
Self-citationJebaseeli, T. J., David, D. J., & Jegathesan, V. (2021) · Internet of things · doi:10.1007/978-3-030-63937-2_9 · Cited by 8
Uno, K., Seki, Y., Kasama, K., Wakamatsu, K. K. W., Hashimoto, K., Umezawa, A., Yanaga, K. K., & Kurokawa, Y. (2017) · Asian Journal of Endoscopic Surgery · doi:10.1111/ases.12443 · Cited by 8
“Medication Preop OA (1) OA (2) OA (1) Postop None None None Measurement (mmHg) sBP Preop 142 112 143 Postop 129 123 95 dBP Preop 59 84 65 Postop 75 81 56”
BackgroundSoliman, A. R., Saleem, H. M. E., Meligi, A. A. H. E., Naguib, M., Mohamed, R. S., Abdelaziz, G. R., Rakha, M., Abdelghaffar, S., Hamed, A. E., Hammad, H., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01564-w · Cited by 10
“In the population with type 1 diabetes (T1D), a prevalent issue is the occurrence of autonomic neuropathy and gastroparesis, which can result in complications like nausea, vomiting, and acute dilation of gastric remnants [124].”
Acute Pancreatitis in Patients with a History of Bariatric Surgery: Is It Less Severe?
Kröner, P. T., Simons-Linares, C. R., Kesler, A. M., Abader, P., Afsh, M., Corral, J. E., Rodriguez, J., Vargo, J. J., Raimondo, M., & Chahal, P. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04480-w · Cited by 8
Is there a role for bariatric surgery in patients with severe obesity and type 1 diabetes?
Dessify, B. J., Wood, G. C., Parker, D. M., Carmichael, D., Petrick, A. T., & Daouadi, M. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.10.013 · Cited by 7
Ichikawa, H., Imoto, H., Tanaka, N., Musha, H., Sawada, S., Naitoh, T., Kamei, T., & Unno, M. (2021) · Surgical Case Reports · doi:10.1186/s40792-020-00989-5 · Cited by 6
“It is plausible that incretin hormones may also contribute to the improvement of glucose metabolism in patients with T1DM after bariatric surgery through an inhibition of glucagon secretion via α cells, even in patients without residual β cells [19].”
BackgroundAbi Mosleh, K., Salameh, Y., Ghusn, W., Jawhar, N., Mundi, M. S., Collazo‐Clavell, M. L., Kendrick, M. L., & Ghanem, O. M. (2024) · Clinical Obesity · doi:10.1111/cob.12689 · Cited by 5
“27 With the increasing prevalence of severe obesity in T1D, the demand for effective surgical solutions like MBS is expected to grow, making it a key element in comprehensive diabetes management strategies.”
Vendrame, F., Calhoun, P. M., Bocchino, L. E., Pratley, R. E., & Casu, A. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107884 · Cited by 5
Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?
Argyrakopoulou, G., Gitsi, E., Dalamaga, Μ., & Kokkinos, A. D. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00654-8 · Cited by 4
“…is essential to elucidate the precise mechanisms linking the gut-brain axis to weight regulation in T1DM and to establish the efficacy, safety, and long-term outcomes of these interventions. the long-term outcomes and improve the management strategies for T1DM patients undergoing BS [37, 42].”
Thaher, O., Iaroshevych, V., Driouch, J., Hukauf, M., Croner, R. S., & Stroh, C. (2023) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-023-02788-6 · Cited by 6
“While some studies have reported more complications following RYGB than SG [20, 21], other studies have shown no significant difference between the two groups [22].”
Cornu, E., Gaulier, C., Juttet, P., Beauvy, J., Mezzarobba, V., Proust, A., Berre, J. P. L., & Paepegaey, A. C. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0551 · Cited by 4
Mazidi, M., Rezaie, P., Jangjoo, A., Tavassoli, A., Rajabi, M. T., Kengne, A. P., & Nematy, M. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i7.374 · Cited by 3
Jin, H., Kim, S. H., Chung, Y., Park, D. G., & Kim, Y. J. (2020) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2020.9.2.52 · Cited by 3
“In addition, the diminishing lipotoxicity in the liver and skeletal muscles and improvements in the obesity-associated pro-inflammatory environment following weight loss can also lead to improved insulin resistance [19,23].”
BackgroundCarette, C., Rives‐Lange, C., Shoung, N., Phan, A., Torreton, E., Dutour, A., Detournay, B., & Czernichow, S. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01709-8 · Cited by 2
“While the risk–benefit ratio of BS is favorable in patients with type 2 diabetes, the risk–benefit ratio is still debated in people liv‑ ing with T1D particularly due to concerns about glycemic control, and the risk of hypoglycemia and ketoacidosis [15, 16].”
High preoperative HbA1c does not affect early or late complication rates after bariatric surgery
Shah, K., Gögenür, I., & Gíslason, H. (2023) · Surgical Endoscopy · doi:10.1007/s00464-023-10009-w · Cited by 2
Metabolic effects of duodenojejunal bypass surgery in a rat model of type 1 diabetes
Vangoitsenhoven, R., Wilson, R. L., Sharma, G., Punchai, S., Corcelles, R., Froylich, D., Mulya, A., Schauer, P. R., Brethauer, S. A., Kirwan, J. P., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07741-y · Cited by 2
“1 3 These findings fit the observational data in human T1D that underwent metabolic surgery, where effects on glycemic status are modest at best [29–31], but weight loss in severely obese patients with T1D is significant and results in a significant reduction in insulin requirements [9, 32].”
BackgroundSelf-citationInsulin Dose Adjustment Following Bariatric Surgery, a Review of Available Literature
Kassel, L. E., Berei, J. J., Pitlick, J. M., & Rand, J. E. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211028886 · Cited by 2
Liu, Z., Xiao, L., Jin, C., Xiao, J., & Zhao, W. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s373712 · Cited by 4
“It was reported that patients with T1DM undergoing bariatric surgery could develop postoperative DKA in 20–25% of the cases.(5) Recently, mild hyperglycaemia or even a euglycaemic status with ketoacidosis, which is defined as euglycaemic ketoacidosis (EKA), has also been reported in patients with diabetes.”
BackgroundMetabolic and Bariatric Surgery in Diabetes Management
Valadez, L. Z. M., Frigolet, M. E., Domínguez, R. M., Pescarus, R., Zerrweck, C., Boudreau, V., Doumouras, A. G., Cookson, T. A., & Anvari, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_42 · Cited by 1
Atherosclerosis in patients with type 1 diabetes
Karásek, D. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.135 · Cited by 1
Bariatric Surgery: Can It Perform Benefits or Risks?
Mostafa, T. A.-H., Abdel-Hameed, A. M., & Ahmed, S. A.-K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006090 · Cited by 1
Stellenwert der bariatrischen Chirurgie in der Therapie des Diabetes mellitus
Scherbaum, W. A., & Nitschmann, S. (2017) · Der Internist · doi:10.1007/s00108-017-0290-4 · Cited by 1
Bariatric surgery, family, and identity: an autoethnographic investigation
Brown, D. (2020) · Communication Quarterly · doi:10.1080/01463373.2020.1731698 · Cited by 1
“The scholarly literature in the medical and other health professions continues to produce new knowledge and to refine our understanding of the benefits of bariatric surgery for persons with Type 1 diabetes (Faucher et al., 2016; Kirwan et al., 2016) and Type 2 diabetes (Aminian et al., 2016).”
BackgroundAvery, A. (2021) · Archives of Diabetes & Obesity · doi:10.32474/ado.2021.03.000172
Alves, M., Pedrosa, C. A., Freitas, C., Rocha, G., Albuquerque, I., Duarte, J., Cardoso, L., Carvalho, R., Belo, S., Azevedo, T., et al. (2019) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/na190001 · Cited by 2
Moreno-Fernández, J., & Chico, A. I. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.09.014 · Cited by 1
HIPOGLUCEMIA HIPERINSULINÉMICA POSTPRANDIAL LUEGO DE LA CIRUGÍA BARIÁTRICA
Álvarez, M. G., Gutt, S., Yuma, M., Polo, P., González, S., Menéndez, E., Vanoli, G., Montemerlo, H., Ackerman, M., Coronel, J., et al. (2019) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v53i1.137
Eligibility Criteria for Sleeve Gastrectomy
Shariff, F. U., & Aminian, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-57373-7_9
Self-citationTreatment: Lifestyle and Medication
Khan, A. A., & Hamdy, O. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_29
Rakkini, A. M., Rosaline, L. M. A., Ramya, G., Florence, J. F., Kanmani, R., Juliat, J. K., & Joice, J. A. I. (2023) · International Journal of Zoological Investigations · doi:10.33745/ijzi.2023.v09ispl1.006
“40 is caused by the body's resistance to insulin hormones (Kirwan et al., 2016).”
BackgroundPoulos, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-39168-2_6
Metabolic and bariatric surgery: an update from 2010
Nasri, B., Lim, R. B., Ellsmere, J. C., Fernandes, A. R., & Jones, D. B. (2024) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2024.101549
Tam, K., & Lund, H. (2026) · Springer eBooks · doi:10.1007/978-3-031-90919-1_22-1
Krzizek, E.-C., Brix, J. M., & Ludvik, B. H. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc26-0033
Metadata
- Authors
- Kirwan, J. P., Aminian, A., Kashyap, S. R., Burguera, B., Brethauer, S. A., & Schauer, P. R.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Aminian, Ali
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-05-13
- Volume
- 39
- Issue
- 6
- Pages
- 941-948
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8310563
- OpenAlex
- W2400544139
- Cited by
- 80
- References
- 78
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 13 · 2020: 11 · 2019: 10 · 2018: 6 · 2017: 10 · 2016: 5
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- bariatric surgery, type 1 diabetes, obesity, gastric bypass, weight loss, insulin requirement, HbA1c, glycemic control, diabetic ketoacidosis, hypoglycemia, gastrointestinal motility disorders, postoperative complications
- MeSH terms
- Adult, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Obesity, Postoperative Complications, Risk Factors, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.